...
首页> 外文期刊>International Journal of Nephrology >Impact of Peritoneal Dialysis Treatment on Arterial Stiffness and Vascular Changes in Diabetic Type 2 and Nondiabetic Patients with End-Stage Renal Disease
【24h】

Impact of Peritoneal Dialysis Treatment on Arterial Stiffness and Vascular Changes in Diabetic Type 2 and Nondiabetic Patients with End-Stage Renal Disease

机译:腹膜透析治疗对2型糖尿病和终末期肾脏疾病的非糖尿病患者的动脉僵硬度和血管变化的影响

获取原文

摘要

Diabetes mellitus (DM) is the leading cause of the end-stage renal disease (ESRD). Vascular diseases are the most common cause of morbidity and mortality in the chronic kidney disease. The aim of this study was to analyze the impact of peritoneal dialysis (PD) treatment on morphologic and hemodynamic vascular parameters of carotid arteries in diabetic type 2 and nondiabetic patients with ESRD during the period of one year after the start of PD treatment using ultrasonography of carotid arteries and their relation on uremia and PD inherent factors. Mean intima-media thickness, plaque score, peak systolic velocity, end-diastolic velocity, and carotid diameter significantly decreased 12 months after PD treatment start in both groups. Significant reduction in median serum endothelin-1 concentration after 12 months on PD treatment was observed in the group of patients with DM (7.6–5.9 pg/mL) and also in group of patients without DM (3.6–3.3 pg/mL). Also median nitric oxide concentration significantly increased after 12 months on PD compared to baseline levels both in patients with DM (25.0–34.3 μmol/L) as was observed in patients without DM (49.6–56.5 μmol/L). PD treatment, with the regulation of these vasoactive molecules and other vascular risk factors, significantly contributes to vascular remodeling, especially in DM patients.
机译:糖尿病(DM)是终末期肾脏疾病(ESRD)的主要原因。在慢性肾脏疾病中,血管疾病是发病率和死亡率的最常见原因。这项研究的目的是分析使用PD超声检查腹膜透析(PD)治疗对2型糖尿病和非糖尿病ESRD患者在开始治疗后一年内颈动脉的形态和血液动力学血管参数的影响。颈动脉及其与尿毒症和PD内在因素的关系。两组PD治疗开始后12个月,平均内膜中层厚度,斑块评分,峰值收缩速度,舒张末期速度和颈动脉直径均明显降低。在患有DM的患者组(7.6–5.9μpg / mL)和没有DM的患者组(3.6–3.3μpg / mL)中,PD治疗12个月后血清内皮素-1的中值显着降低。与非糖尿病患者(49.6-56.5μmol/ L)相比,糖尿病患者(PD)12个月后的中值一氧化氮浓度也显着增加(25.0-34.3μmol/ L)。 PD治疗,通过调节这些血管活性分子和其他血管危险因素,可显着促进血管重构,尤其是在DM患者中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号